General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
First Solar (NASDAQ:FSLR) PT Raised to $227.00 | news.google.com • |
First Solar (NASDAQ:FSLR) Shares Gap Up to $174.29 | news.google.com • |
First Solar (NASDAQ:FSLR) Lifted to Overweight at Wells Fargo & Company | news.google.com • |
If Nvidia Stock Slips, First Solar, Twilio, and These Other Tech Stocks May Be Solid Bets | news.google.com • |
6,125 Shares in First Solar, Inc. (NASDAQ:FSLR) Purchased by Ninepoint Partners LP | news.google.com • |
If Nvidia Stock Slips, First Solar, Twilio, and These Other Tech Stocks May Be Solid Bets | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | 2.03 | N/A | N/A | N/A |
2024-02-27 | 2023-12 | 3.19 | 3.25 | 0.06 | 1.88% |
2023-10-31 | 2023-09 | 2.09 | 2.5 | 0.41 | 19.62% |
2023-07-27 | 2023-06 | 0.95 | 1.85 | 0.9 | 94.74% |
2023-04-27 | 2023-03 | 0.99 | 0.4 | -0.59 | -59.60% |
2023-02-28 | 2022-12 | -0.18 | -0.07 | 0.11 | 61.11% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-19 | Exane BNP Paribas | Upgrade | Outperform | |
2023-10-18 | JP Morgan | Upgrade | Neutral | Overweight |
2023-10-17 | Citigroup | Upgrade | Neutral | Neutral |
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-11 | Barclays | Upgrade | Equal-Weight | Overweight |
2023-10-05 | Piper Sandler | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-27 | AHEARN MICHAEL J | Director | 147.87K | Stock Award(Grant) |
2024-04-03 | ANTOUN GEORGES J | Officer | 37.41K | Sale |
2024-03-27 | CHAPMAN RICHARD D | Director | 25.90K | Stock Award(Grant) |
2024-04-03 | GLOECKLER MARKUS | Chief Technology Officer | 12.54K | Sale |
2024-03-27 | HAMBRO GEORGE A | Director | 0.00 | Stock Award(Grant) |
2024-03-27 | KENNEDY RAYMOND CRAIG | Director | 15.91K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 13.21M | 2.51B | 12.37% |
2023-06-29 | Vanguard Group Inc | 11.76M | 2.24B | 11.01% |
2023-06-29 | JP Morgan Chase & Company | 6.47M | 1.23B | 6.05% |
2023-06-29 | FMR, LLC | 5.81M | 1.10B | 5.44% |
2023-06-29 | State Street Corporation | 4.42M | 840.06M | 4.14% |
2023-06-29 | Invesco Ltd. | 3.34M | 635.10M | 3.13% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | JP Morgan Large Cap Growth Fund | 4.10M | 778.89M | 3.84% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.16M | 600.61M | 2.96% |
2023-06-29 | Vanguard 500 Index Fund | 2.37M | 449.60M | 2.21% |
2023-06-29 | Vanguard Mid-Cap Index Fund | 2.35M | 446.77M | 2.20% |
2023-08-30 | iShares Global Clean Energy ETF | 1.65M | 311.80M | 1.54% |
2023-05-30 | Fidelity 500 Index Fund | 1.11M | 225.17M | 1.04% |
155 this week plzz
For beginners in trading and investing, it's crucial to grasp that success in these fields goes beyond just technical analysis. Consistently investing over an extended period typically yields better results than attempting to time the market through short-term buying and selling based on fluctuations. Learning plays a vital role in achieving success in trading and investing. Staying updated on current trends and strategies can assist businesses in staying ahead of the curve and making well-informed decisions. I'm pleased that the insights and strategies have proven beneficial to me. Presently, I am generating $17,500 every ten days with my initial investment of $1,700. Feel free to reach out to Salome_crypto_trader via direct message on Instagram to kickstart your journey.https://www.instagram.com/salome_crypto_trader?igsh=MW5zOGdtb3lieGU3MQ==
$PTC Therapeutics(PTCT.US)$ Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.
Frustrating watching this move 4 to 5 percent between 4am and 7am.
Keep buying Bear Down!!!
$FSLR how about a short squeeze this week!!
vaya dia
$FSLR.. Biden’s speech tomorrow with make energy sector booooom!
Def not a buy nor a sell. Its a hold. $FSLR $100 is a magnet. PEG is 0.96
Is this not way over valued? $FSLR